On October 15, PAN CEO Amy Comstock Rick was part of a panel discussion at a meeting titled, “Perspectives on Clinical Trial Data Sharing,” which was sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA).
The panel focused on the new Principles for Responsible Clinical Trial Data Sharing  released by PhRMA on July 24. Under the new Principles, PhRMA member companies will increase the amount of information that they share with researchers, patients, and the public. A similar movement to share clinical trial data is occurring in Europe.
During the October 15 meeting, Amy stressed support for PhRMA’s commitment to share clinical trial data with researchers, but also highlighted the challenge of interoperability of data and protecting patient privacy. Sharing data from clinical trials is important but only if that data can then be used in other research effectively. Many researchers and patient advocates see interoperability as the next step in ensuring data is used to bring us closer to better treatments and cures.
PhRMA’s Principles will take effect January 1, 2014.
Date originally posted: October 25, 2013.